Lifevantage PE Ratio 2006-2019 | LFVN
Current and historical p/e ratio for Lifevantage (LFVN) from 2006 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Lifevantage PE ratio as of March 31, 2020 is 12.41.
| Lifevantage PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2020-03-31 |
10.30 |
|
12.88 |
| 2019-12-31 |
15.61 |
$0.80 |
19.51 |
| 2019-09-30 |
13.70 |
$0.56 |
24.46 |
| 2019-06-30 |
12.98 |
$0.50 |
25.96 |
| 2019-03-31 |
14.29 |
$0.45 |
31.76 |
| 2018-12-31 |
13.19 |
$0.45 |
29.31 |
| 2018-09-30 |
10.99 |
$0.41 |
26.80 |
| 2018-06-30 |
6.37 |
$0.41 |
15.54 |
| 2018-03-31 |
3.61 |
$0.21 |
17.19 |
| 2017-12-31 |
4.76 |
$0.09 |
52.89 |
| 2017-09-30 |
4.22 |
$0.09 |
46.89 |
| 2017-06-30 |
4.33 |
$0.11 |
39.36 |
| 2017-03-31 |
5.37 |
$0.26 |
20.65 |
| 2016-12-31 |
8.15 |
$0.33 |
24.70 |
| 2016-09-30 |
9.46 |
$0.42 |
22.52 |
| 2016-06-30 |
13.60 |
$0.42 |
32.38 |
| 2016-03-31 |
9.10 |
$0.26 |
35.00 |
| 2015-12-31 |
9.52 |
$0.26 |
36.62 |
| 2015-09-30 |
5.67 |
$0.22 |
25.77 |
| 2015-06-30 |
3.71 |
$0.49 |
7.57 |
| 2015-03-31 |
5.53 |
$0.63 |
8.78 |
| 2014-12-31 |
9.10 |
$0.70 |
13.00 |
| 2014-09-30 |
7.98 |
$0.84 |
9.50 |
| 2014-06-30 |
10.08 |
$0.70 |
14.40 |
| 2014-03-31 |
9.17 |
$0.56 |
16.38 |
| 2013-12-31 |
11.55 |
$0.63 |
18.34 |
| 2013-09-30 |
16.66 |
$0.42 |
39.69 |
| 2013-06-30 |
16.24 |
$0.42 |
38.69 |
| 2013-03-31 |
16.45 |
$0.70 |
23.51 |
| 2012-12-31 |
15.33 |
$0.14 |
109.50 |
| 2012-09-30 |
24.01 |
$0.49 |
49.01 |
| 2012-06-30 |
19.81 |
$0.42 |
47.17 |
| 2012-03-31 |
26.32 |
$-3.78 |
0.00 |
| 2011-12-31 |
10.01 |
$-4.34 |
0.00 |
| 2011-09-30 |
10.50 |
$-4.27 |
0.00 |
| 2011-06-30 |
10.50 |
$-4.34 |
0.00 |
| 2011-03-31 |
4.97 |
$-0.98 |
0.00 |
| 2010-12-31 |
2.73 |
$-1.05 |
0.00 |
| 2010-09-30 |
3.50 |
$-1.54 |
0.00 |
| 2010-06-30 |
3.57 |
$-1.47 |
0.00 |
| 2010-03-31 |
2.73 |
$-1.68 |
0.00 |
| 2009-12-31 |
1.75 |
$-1.54 |
0.00 |
| 2009-09-30 |
2.70 |
$-1.61 |
0.00 |
| 2009-06-30 |
4.69 |
$-1.82 |
0.00 |
| 2009-03-31 |
5.43 |
$-1.26 |
0.00 |
| 2008-12-31 |
1.40 |
$-0.63 |
0.00 |
| 2008-09-30 |
1.40 |
$-0.63 |
0.00 |
| 2008-06-30 |
1.75 |
$-0.56 |
0.00 |
| 2008-03-31 |
1.65 |
$-0.49 |
0.00 |
| 2007-12-31 |
1.40 |
$-0.28 |
0.00 |
| 2007-09-30 |
1.54 |
$-0.14 |
0.00 |
| 2007-06-30 |
1.68 |
$-0.14 |
0.00 |
| 2007-03-31 |
2.38 |
0 |
0.00 |
| 2006-12-31 |
3.08 |
0 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.147B |
$0.226B |
|
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
|
